COMMUNIQUÉS West-GlobeNewswire

Bone Therapeutics SA : Reports Full Year 2017 Results

25/04/2018 - 07:01

Regulated information Bone Therapeutics Reports Full Year 2017 Results Strong clinical progress in ALLOB ® spinal fusion and delayed union trials Leadership team strengthened with appointments of Jean Stéphenne as [...]

Bone Therapeutics SA : Publie ses résultats annuels 2017

25/04/2018 - 07:01

Information réglementée Bone Therapeutics publie ses résultats annuels 2017 Progrès cliniques importants avec ALLOB ® dans la fusion vertébrale et dans les fractures avec retard de consolidation Renforcement de l'équipe [...]

Shire plc : Shire announces revised proposal and extension of PUSU deadline to 8 May 2018

25/04/2018 - 01:11

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT [...]

Compass Cannabis Closes Over-Subscribed Non-Brokered Financing

24/04/2018 - 23:17

CALGARY, Alberta, April 24, 2018 (GLOBE NEWSWIRE) -- 10330698 Canada Ltd. (dba Compass Cannabis Clinic, or “the Company”) is a medical cannabis consultation company with thirty nine clinics that are now open or signed [...]

Psychemedics Announces 1Q Record Revenues and Dividend Increase of 20%

24/04/2018 - 23:15

ACTON, Mass., April 24, 2018 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD ) today announced first quarter financial results for the period ended March 31, 2018. The Company also announced a quarterly [...]

Osiris Therapeutics to Present Clinical and Scientific Studies at Symposium on Advanced Wound Care and Wound Healing Society Spring Conference

24/04/2018 - 22:30

Experts to host a variety of presentations from April 25 – April 29, 2018, in Charlotte, North Carolina COLUMBIA, Maryland, April 24, 2018 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (OTC Pink Sheets:OSIR), a leading [...]

ERYTECH Announces Filing of 2017 “Document de Référence” and 2017 Annual Report on Form 20-F

24/04/2018 - 22:30

LYON, France, April 24, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris:ERYP) (Nasdaq: ERYP ) , the clinical-stage biopharmaceutical company developing innovative therapies for severe forms of cancer and orphan [...]

ERYTECH annonce le dépôt de son Document de Référence 2017 et de son Form 20-F 2017

24/04/2018 - 22:30

LYON, France, 24 avr. 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris:ERYP) (Nasdaq: ERYP ) , société biopharmaceutique de stade clinique développant à partir de sa plateforme propriétaire d’encapsulation de [...]

Flexion Therapeutics to Present Data on ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) at the Academy of Managed Care Pharmacy Annual Meeting 2018

24/04/2018 - 22:30

Post-hoc analysis indicated ZILRETTA provided significant improvements in pain and function in patients with unilateral knee osteoarthritis Abstract receives silver ribbon designation BURLINGTON, Mass., April 24, 2018 ( [...]

Reata Announces New Preclinical Data Demonstrating the Potential of Omaveloxolone in the Treatment of Friedreich’s Ataxia and Other Severe Neurological Diseases

24/04/2018 - 22:15

IRVING, Texas, April 24, 2018 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA ) (Reata or Company), a clinical-stage biopharmaceutical company, today announced new preclinical data demonstrating that [...]

Supernus to Host First Quarter 2018 Earnings Conference Call

24/04/2018 - 22:15

ROCKVILLE, Md., April 24, 2018 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN ), a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central [...]

Aclaris Therapeutics Announces Appointment of Bryan Reasons as a Director and Chairman of the Audit Committee

24/04/2018 - 22:05

WAYNE, Pa., April 24, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS ), a dermatologist-led biopharmaceutical company committed to identifying, developing, and commercializing innovative therapies to [...]

Aclaris Therapeutics to Announce First Quarter 2018 Financial Results on May 8, 2018

24/04/2018 - 22:05

WAYNE, Pa., April 24, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS ), a dermatologist-led biopharmaceutical company committed to identifying, developing, and commercializing innovative therapies to [...]

AveXis Presents Initial Data from Pivotal U.S. Trial for SMA Type 1 and 24-Month Follow-Up Data from Phase 1 Trial of AVXS-101 in SMA Type 1 at the Annual Meeting of the American Academy of Neurology

24/04/2018 - 22:01

– A mean increase in CHOP-INTEND of 17.3 was observed at three months post gene therapy in SMA Type 1 U.S. pivotal trial – – All patients in the therapeutic dose cohort in the Phase 1 trial were alive and event-free at [...]

Eloxx Pharmaceuticals Announces Proposed Public Offering of Common Stock

24/04/2018 - 22:01

WALTHAM, Mass., April 24, 2018 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (“Eloxx”) (OTCQB:ELOX) today announced that it intends to offer and sell, subject to market and other conditions, 5,000,000 shares of its [...]

Progressive Care: PharmCo Rolls Out Online Prescription Application

24/04/2018 - 18:47

MIAMI, April 24, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, announced roll out of its online prescription management solution. Patients of PharmCo’s can [...]

News Release: Essilor 2018 Annual General Meeting

24/04/2018 - 18:30

Essilor 2018 Annual General Meeting PDF Version of the news release Adoption of all resolutions Dividend payment of €1.53 per share, up for the 25th consecutive year Charenton-le-Pont, France (April 24, 2018) - Essilor [...]

Communiqué : Assemblée Générale Essilor 2018

24/04/2018 - 18:30

Assemblée Générale Essilor 2018 Version PDF du communiqué Adoption de l'ensemble des résolutions Versement d'un dividende de 1,53 € par action, en hausse pour la 25ème année consécutive Charenton-le-Pont, France (le 24 [...]

League and eSight Partner to Proactively Provide Employers With an Unprecedented Solution for Blindness in the Workplace

24/04/2018 - 17:53

TORONTO, April 24, 2018 (GLOBE NEWSWIRE) -- League Inc., the disruptive health benefits platform, and eSight , the developer of breakthrough electronic glasses that help the legally blind see, are proudly joining forces [...]